Cleveland-Cliffs Extends POSCO Deal Timeline to H1 2026 Amid Q4 Losses
Cleveland-Cliffs reports Q4 2025 losses but sees brighter 2026 outlook. POSCO partnership negotiations extended to first half 2026. Stock drops 19% on disappointing results.
NOTRELOAD AI
Playboy Stock Surges on $122M China Business Deal
Playboy (PLBY) shares jump 28% as company announces $122 million deal to sell half its China business to UTG Brands Management Group, with proceeds earmarked for debt reduction.
AppLovin Stock Jumps as CapitalWatch Retracts Key Allegations But Maintains Critical Stance
AppLovin shares rise after CapitalWatch corrects claims about major shareholder Hao Tang while maintaining its negative outlook on the company's financial structure.
Wedbush Starts Coverage on Zura Bio with Positive Outlook
Wedbush gives Zura Bio an Outperform rating and $15 target, highlighting upcoming clinical catalysts and potential stock growth through 2026.
Workday CEO Shakeup: Co-Founder Aneel Bhusri Returns to Lead AI Push
Workday announces immediate CEO change as co-founder Aneel Bhusri replaces Carl Eschenbach to lead company's AI transformation. Stock drops 5% on news.
Novo Nordisk Sues Hims & Hers Over Weight-Loss Drug Knockoffs
Danish pharma giant Novo Nordisk files patent lawsuit against telehealth company Hims & Hers for selling unauthorized versions of Wegovy and Ozempic weight-loss medications.